VOYA Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.02M | Buy |
87,776
+13,416
| +18% | +$735K | ﹤0.01% | 869 |
|
|
2026
Q1 | $4.2M | Sell |
74,360
-33,063
| -31% | -$1.93M | ﹤0.01% | 898 |
|
|
2025
Q4 | $6.38M | Buy |
107,423
+28,343
| +36% | +$1.54M | 0.01% | 778 |
|
|
2025
Q3 | $4.28M | Sell |
79,080
-74,004
| -48% | -$4.23M | ﹤0.01% | 925 |
|
|
2025
Q2 | $8.42M | Buy |
153,084
+52,356
| +52% | +$3.08M | 0.01% | 783 |
|
|
2025
Q1 | $7.12M | Buy |
100,728
+13,109
| +15% | +$882K | 0.01% | 835 |
|
|
2024
Q4 | $5.76M | Sell |
87,619
-2,726
| -3% | -$183K | 0.01% | 918 |
|
|
2024
Q3 | $6.35M | Buy |
90,345
+878
| +1% | +$73.4K | 0.01% | 913 |
|
|
2024
Q2 | $7.37M | Buy |
89,467
+4,534
| +5% | +$377K | 0.01% | 853 |
|
|
2024
Q1 | $7.42M | Sell |
84,933
-7,829
| -8% | -$701K | 0.01% | 849 |
|
|
2023
Q4 | $8.94M | Buy |
92,762
+4,662
| +5% | +$412K | 0.01% | 783 |
|
|
2023
Q3 | $7.8M | Sell |
88,100
-442
| -0.5% | -$39.3K | 0.01% | 797 |
|
|
2023
Q2 | $7.67M | Buy |
88,542
+7,261
| +9% | +$683K | 0.01% | 826 |
|
|
2023
Q1 | $7.9M | Buy |
81,281
+4,584
| +6% | +$475K | 0.01% | 804 |
|
|
2022
Q4 | $7.94M | Buy |
76,697
+3,705
| +5% | +$348K | 0.01% | 804 |
|
|
2022
Q3 | $6.19M | Buy |
72,992
+48,645
| +200% | +$4.33M | 0.01% | 875 |
|
|
2022
Q2 | $2.02M | Sell |
24,347
-1,245
| -5% | -$99.1K | 0.01% | 1108 |
|
|
2022
Q1 | $1.97M | Hold |
25,592
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q4 | $2.26M | Sell |
25,592
-3,369
| -12% | -$278K | ﹤0.01% | 1104 |
|
|
2021
Q3 | $2.24M | Sell |
28,961
-126
| -0.4% | -$9.94K | ﹤0.01% | 1123 |
|
|
2021
Q2 | $2.43M | Sell |
29,087
-27,560
| -49% | -$2.18M | ﹤0.01% | 1115 |
|
|
2021
Q1 | $4.28M | Sell |
56,647
-576,153
| -91% | -$47.1M | 0.01% | 897 |
|
|
2020
Q4 | $55.5M | Buy |
632,800
+28,662
| +5% | +$2.27M | 0.11% | 175 |
|
|
2020
Q3 | $46M | Sell |
604,138
-647,917
| -52% | -$65.6M | 0.1% | 191 |
|
|
2020
Q2 | $154M | Buy |
1,252,055
+397,054
| +46% | +$39.5M | 0.36% | 60 |
|
|
2020
Q1 | $72.2M | Sell |
855,001
-100,274
| -10% | -$8.64M | 0.19% | 120 |
|
|
2019
Q4 | $80.8M | Buy |
955,275
+159,125
| +20% | +$12M | 0.17% | 137 |
|
|
2019
Q3 | $53.7M | Sell |
796,150
-27,672
| -3% | -$2.13M | 0.12% | 178 |
|
|
2019
Q2 | $70.6M | Buy |
823,822
+19,570
| +2% | +$1.67M | 0.15% | 149 |
|
|
2019
Q1 | $71.4M | Sell |
804,252
-28,073
| -3% | -$2.6M | 0.16% | 137 |
|
|
2018
Q4 | $70.9M | Buy |
832,325
+455,754
| +121% | +$43.4M | 0.17% | 124 |
|
|
2018
Q3 | $36.5M | Buy |
376,571
+36,494
| +11% | +$3.64M | 0.08% | 266 |
|
|
2018
Q2 | $32M | Sell |
340,077
-15,825
| -4% | -$1.39M | 0.07% | 311 |
|
|
2018
Q1 | $28.9M | Sell |
355,902
-399,609
| -53% | -$34.3M | 0.06% | 319 |
|
|
2017
Q4 | $67.4M | Sell |
755,511
-40,912
| -5% | -$3.56M | 0.14% | 161 |
|
|
2017
Q3 | $74.1M | Buy |
796,423
+101,595
| +15% | +$8.98M | 0.16% | 140 |
|
|
2017
Q2 | $63.1M | Buy |
694,828
+43,029
| +7% | +$3.91M | 0.14% | 161 |
|
|
2017
Q1 | $57.2M | Buy |
651,799
+49,170
| +8% | +$4.37M | 0.13% | 158 |
|
|
2016
Q4 | $49.9M | Sell |
602,629
-12,709
| -2% | -$1.09M | 0.12% | 172 |
|
|
2016
Q3 | $56.9K | Sell |
615,338
-10,009
| -2% | -$943K | 0.11% | 159 |
|
|
2016
Q2 | $48.7M | Buy |
625,347
+145,907
| +30% | +$12.4M | 0.12% | 168 |
|
|
2016
Q1 | $39.5M | Sell |
479,440
-6,560
| -1% | -$534K | 0.1% | 195 |
|
|
2015
Q4 | $50.9M | Sell |
486,000
-114,138
| -19% | -$11.9M | 0.12% | 167 |
|
|
2015
Q3 | $63.2M | Sell |
600,138
-26,316
| -4% | -$3.52M | 0.16% | 139 |
|
|
2015
Q2 | $85.7M | Sell |
626,454
-13,107
| -2% | -$1.62M | 0.2% | 120 |
|
|
2015
Q1 | $79.7M | Buy |
639,561
+569,545
| +813% | +$60.3M | 0.18% | 127 |
|
|
2014
Q4 | $6.33M | Sell |
70,016
-3,753
| -5% | -$312K | 0.01% | 732 |
|
|
2014
Q3 | $5.32M | Sell |
73,769
-726
| -1% | -$47.7K | 0.01% | 777 |
|
|
2014
Q2 | $4.63M | Sell |
74,495
-9,128
| -11% | -$551K | 0.01% | 847 |
|
|
2014
Q1 | $5.7M | Buy |
83,623
+90
| +0.1% | +$6.63K | 0.01% | 770 |
|
|
2013
Q4 | $5.87M | Sell |
83,533
-1,956
| -2% | -$133K | 0.01% | 754 |
|
|
2013
Q3 | $6.17M | Sell |
85,489
-369
| -0.4% | -$24.5K | 0.02% | 718 |
|
|
2013
Q2 | $4.79M | Buy |
+85,858
| New | +$5.35M | 0.01% | 786 |
|
Other funds holding BMRN
VPC
VOYA Investment Management's BMRN Position: Q2 2026 in Review
VOYA Investment Management increased its BioMarin Pharmaceuticals (BMRN) stake by 18% in Q2 2026, buying an estimated $735K and bringing the position to 87,776 shares worth $5.02M. The position accounts for ﹤0.01% of the portfolio, ranked #869.
VOYA Investment Management first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $154M in Q2 2020. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- VOYA Investment Management held 87,776 shares of BioMarin Pharmaceuticals worth $5.02M as of Q2 2026.
- VOYA Investment Management bought 13,416 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $735K.
- BioMarin Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #869 holding.
- VOYA Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- VOYA Investment Management's BioMarin Pharmaceuticals position peaked at $154M in Q2 2020.
- 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.